Viewing Study NCT06839703

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2026-01-26 @ 6:50 PM
Study NCT ID: NCT06839703
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-02-21
First Post: 2025-02-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma
Sponsor: Prof. Dr. Dirk Reinhardt
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None High-risk GD2-Positive Ewing Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Biomarker View
None GD2 expression View
None targeted therapy View
None high-risk Ewing Sarcoma View